New Prostate Cancer Tests Aim To Reduce The Death Rate
About a dozen new medical tests are coming to market that aim to more accurately diagnose prostate cancer and go well beyond the standard PSA (prostate-specific antigen) blood screenings used today. Several of them may even allow men to forego getting a biopsy that more than 1 million men diagnosed with prostate cancer undergo each year. That's because these new tests will help doctors distinguish between aggressive disease and slow-growing tumors.
For men entering the latter half of their lives, a diagnosis of prostate cancer can be frightening. About 30 million men are screened for prostate cancer each year, according to the Centers for Disease Control and Prevention. Of that number, more than 180,000 will be diagnosed annually, and a smaller subset — 26,000 — will die of the disease, said the Prostate Cancer Foundation.
For men entering the latter half of their lives, a diagnosis of prostate cancer can be frightening. About 30 million men are screened for prostate cancer each year, according to the Centers for Disease Control and Prevention. Of that number, more than 180,000 will be diagnosed annually, and a smaller subset — 26,000 — will die of the disease, said the Prostate Cancer Foundation.